This week, Chinese AI firm DeepSeek made waves by claiming its new AI model surpasses OpenAI’s at a fraction of the cost, with their large language model trained for just $5.6 million. Concerns arose over the exorbitant amounts tech giants spend on AI computing infrastructure, leading to a $600 billion market cap drop for Nvidia. While DeepSeek’s assertions caused investor panic, experts questioned the validity of their claims compared to OpenAI’s ChatGPT, casting doubt on the true impact of DeepSeek’s technology in the AI landscape.
Full Article
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The US FDA approved Vertex Pharmaceuticals' Journavx, a new pain pill designed to reduce addiction and overdose risks associated with opioids, offering an alternative for short-term pain relief post-surgery or injuries. The drug, priced at $15.50 per pill, works by blocking pain-signaling proteins rather than targeting brain receptors like opioids, showing promise despite modest effectiveness and some side effects. While Vertex faces challenges with its chronic pain drug pipeline, they plan to proceed with further...
Read more